SEC Form 4 · accession 0001179110-15-002375
ALBANY MOLECULAR RESEARCH INC · AMRI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ambra Constance M D
10% Owner
Period of report
Feb 10, 2015
Accepted (ET)
Feb 12, 2015 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001065087
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 10, 2015 | S | 20,000 | $16.91 | D | 2,495,818 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted on May 9, 2014.
- F2Mrs. D'Ambra jointly owns 2,495,818 shares with her spouse. Dr. D'Ambra and Mrs. D'Ambra may be deemed to beneficially own an additional 375,000 shares, which are held by Thomas D'Ambra SLAT Trust (the "Trust Shares"). The trustee of the Thomas D'Ambra SLAT trust is Dr. and Mrs. D'Ambra's son, Geoffrey D'Ambra. Mrs. D'Ambra disclaims beneficial ownership of the Trust Shares, and this report shall not be deemed an admission that she is the beneficial owner of the Trust Shares, except to the extent of her precuniary interest, if any, in the Trust Shares.